VRTX Income Statement
Vertex Pharmaceuticals Inc - Revenue, Expenses & Profit Analysis
Stock Price
$454.67
Market Cap
$118.09B
P/E Ratio
32.4
EPS (TTM)
$14.23
Most Recent Quarter
Period: 2024-12-31(2024-12-31)
Revenue
Total sales from operations
$11.02B
+11.7% YoY
Net Income
Bottom line profit
$-535.60M
Margin: 0.3%
Earnings Per Share (Diluted)
Net income per share
$-2.08
Profitability Metrics
Gross Margin
52.7%
Operating Margin
0.4%
Net Margin
0.3%
Return on Equity
0.2%
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2024-12-31 | $11.02B | - | - | $-535.60M | $-2.08 |
| 2023-12-31 | $9.87B | - | - | $3.62B | $13.89 |
| 2022-12-31 | $8.93B | - | - | $3.32B | $12.82 |
| 2021-12-31 | $7.57B | - | - | $2.34B | $9.01 |
| 2020-12-31 | $1.63B | - | - | $2.71B | $2.30 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is VRTX's revenue?
VRTX's most recent quarterly revenue was $11.02B, representing a growth of 11.7% year-over-year.
Is VRTX profitable?
VRTX reported a loss of $535.60M in the most recent quarter. The net profit margin is 0.3%.
What is VRTX's operating income?
Operating income data is available in the income statement.
What is VRTX's earnings per share (EPS)?
VRTX reported diluted earnings per share of $-2.08 in the most recent quarter.
What is VRTX's gross profit margin?
VRTX has a gross profit margin of 52.7%, indicating the profitability of core operations before operating expenses.